These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34735756)

  • 1. Designing Clinical Trials in "Regular" COPD Versus Alpha-1 Antitrypsin Deficiency-Associated COPD: "More Alike Than Unalike?".
    Stoller JK
    Chronic Obstr Pulm Dis; 2022 Jan; 9(1):95-102. PubMed ID: 34735756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review.
    Edgar RG; Patel M; Bayliss S; Crossley D; Sapey E; Turner AM
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1295-1308. PubMed ID: 28496314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence of emphysema post-lung transplantation in a patient with alpha 1 antitrypsin deficiency (AATD).
    Ataya A
    Respir Med Case Rep; 2020; 31():101309. PubMed ID: 33304809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
    Rahaghi FF; Miravitlles M
    Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune activation in α1-antitrypsin-deficiency emphysema. Beyond the protease-antiprotease paradigm.
    Baraldo S; Turato G; Lunardi F; Bazzan E; Schiavon M; Ferrarotti I; Molena B; Cazzuffi R; Damin M; Balestro E; Luisetti M; Rea F; Calabrese F; Cosio MG; Saetta M
    Am J Respir Crit Care Med; 2015 Feb; 191(4):402-9. PubMed ID: 25412116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similarities in the Computed Tomography Appearance in α1-Antitrypsin Deficiency and Smoking-Related Chronic Obstructive Pulmonary Disease in a Smoking Collective.
    Konietzke P; Jobst B; Wagner WL; Jarosch I; Graber R; Kenn K; Kauczor HU; Wielpütz MO
    Respiration; 2018; 96(3):231-239. PubMed ID: 29940576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spectrum of clinical sequelae associated with alpha-1 antitrypsin deficiency.
    Tejwani V; Stoller JK
    Ther Adv Chronic Dis; 2021; 12_suppl():2040622321995691. PubMed ID: 34408829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The important role of primary care providers in the detection of alpha-1 antitrypsin deficiency.
    Lascano JE; Campos MA
    Postgrad Med; 2017 Nov; 129(8):889-895. PubMed ID: 28929906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD.
    Green CE; Vayalapra S; Hampson JA; Mukherjee D; Stockley RA; Turner AM
    Thorax; 2015 Oct; 70(10):939-45. PubMed ID: 26141072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging in alpha-1 antitrypsin deficiency: a window into the disease.
    Huang YT; Wencker M; Driehuys B
    Ther Adv Chronic Dis; 2021; 12_suppl():20406223211024523. PubMed ID: 34408834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of Alpha-1 Antitrypsin-Deficient Individuals in the Long-term Oxygen Treatment Trial and Comparison with Other Subjects with Chronic Obstructive Pulmonary Disease.
    Stoller JK; Aboussouan LS; Kanner RE; Wilson LA; Diaz P; Wise R;
    Ann Am Thorac Soc; 2015 Dec; 12(12):1796-804. PubMed ID: 26653189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in understanding and treating COPD related to α
    Henao MP; Craig TJ
    Expert Rev Respir Med; 2016 Dec; 10(12):1281-1294. PubMed ID: 27771979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary
    Lessard E; Young HM; Bhalla A; Pike D; Sheikh K; McCormack DG; Ouriadov A; Parraga G
    Acad Radiol; 2017 Nov; 24(11):1402-1411. PubMed ID: 28645458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.
    Casas F; Blanco I; Martínez MT; Bustamante A; Miravitlles M; Cadenas S; Hernández JM; Lázaro L; Rodríguez E; Rodríguez-Frías F; Torres M; Lara B
    Arch Bronconeumol; 2015 Apr; 51(4):185-92. PubMed ID: 25027067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The natural history of lung function after lung transplantation for α(1)-antitrypsin deficiency.
    Banga A; Gildea T; Rajeswaran J; Rokadia H; Blackstone EH; Stoller JK
    Am J Respir Crit Care Med; 2014 Aug; 190(3):274-81. PubMed ID: 25003824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the Adult.
    Sandhaus RA; Turino G; Brantly ML; Campos M; Cross CE; Goodman K; Hogarth DK; Knight SL; Stocks JM; Stoller JK; Strange C; Teckman J
    Chronic Obstr Pulm Dis; 2016 Jun; 3(3):668-682. PubMed ID: 28848891
    [No Abstract]   [Full Text] [Related]  

  • 17. Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis Study. Alpha-1 Protocol.
    Strange C; Senior RM; Sciurba F; O'Neal S; Morris A; Wisniewski SR; Bowler R; Hochheiser HS; Becich MJ; Zhang Y; Leader JK; Methé BA; Kaminski N; Sandhaus RA;
    Ann Am Thorac Soc; 2015 Oct; 12(10):1551-60. PubMed ID: 26153726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, Placebo-Controlled Trials in Alpha-1 Antitrypsin Deficiency.
    Sandhaus RA
    Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S370-3. PubMed ID: 27564674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of the CAT, LCOPD, EQ-5D and COPDSS scales in understanding the impact of lung disease in patients with alpha-1 antitrypsin deficiency.
    Manca S; Rodriguez E; Huerta A; Torres M; Lazaro L; Curi S; Pirina P; Miravitlles M
    COPD; 2014 Sep; 11(5):480-8. PubMed ID: 24832005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endobronchial coil treatment in severe emphysema patients with alpha-1 antitrypsin deficiency.
    Perotin JM; Leroy S; Marquette CH; Mal H; Dutau H; Bourdin A; Vergnon JM; Pison C; Barbe C; Deslee G;
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3645-3649. PubMed ID: 30464447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.